(Q39922451)

15 September 2017

1 reference

title

Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs (English)

1 reference

15 September 2017

L E Hollister

1

1 reference

15 September 2017

1 January 1972

1 reference

15 September 2017

1 reference

15 September 2017

4

1 reference

15 September 2017

321-360

1 reference

15 September 2017

5

1 reference

COMPLICATIONS FROM PSYCHOTHERAPEUTIC DRUGS--1964.

15 September 2017

1 reference

12 December 2020

Relationship between depression and mania

1 reference

12 December 2020

Biochemical Aspects of Lithium in Affective Disorders

1 reference

12 December 2020

1 reference

12 December 2020

Relationship Between Serum Lithium Level and Clinical Response in Acute Mania Treated with Lithium

1 reference

12 December 2020

Controlled trial of Penfluridol in Acute Psychosis

1 reference

12 December 2020

A study of phenothiazines with male and female chronically ill schizophrenic patients

1 reference

12 December 2020

Value of plasma-lithium monitoring

1 reference

12 December 2020

A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man

1 reference

12 December 2020

DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS

1 reference

12 December 2020

Lithium carbonate: a clinical study.

1 reference

12 December 2020

Catecholamines and mania: The effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism

1 reference

12 December 2020

Peritoneal dialysis for lithium poisoning

1 reference

12 December 2020

Overdosage of psychotropic drugs: a review. I. Major and minor tranquilizers

1 reference

12 December 2020

Efficacy of lithium as acute treatment of manic-depressive illness

1 reference

12 December 2020

Lithium and leukocytosis

1 reference

12 December 2020

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

1 reference

12 December 2020

PHENOTHIAZINE TREATMENT IN ACUTE SCHIZOPHRENIA; EFFECTIVENESS: THE NATIONAL INSTITUTE OF MENTAL HEALTH PSYCHOPHARMACOLOGY SERVICE CENTER COLLABORATIVE STUDY GROUP

1 reference

12 December 2020

1 reference

12 December 2020

Patient Rejection of Lithium Carbonate Prophylaxis

1 reference

12 December 2020

Trial of Maintenance Therapy in Schizophrenia

1 reference

12 December 2020

Absorption and excretion of lithium in manic-depressive disease

1 reference

12 December 2020

Distribution of chlorpromazine metabolites in selected organs of psychiatric patients chronically dosed up to the time of death.

1 reference

12 December 2020

Mineral metabolism in mania.

1 reference

12 December 2020

Lithium in psychiatric therapy and prophylaxis

1 reference

12 December 2020

Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine

1 reference

12 December 2020

Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital

1 reference

12 December 2020

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

1 reference

12 December 2020

Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation

1 reference

12 December 2020

Treatment of the acute alcohol withdrawal state: a comparison of four drugs

1 reference

12 December 2020

Prophylactic lithium in affective disorders. Controlled trial

1 reference

12 December 2020

Lithium and rubidium: a role in the affective disorders

1 reference

12 December 2020

PHENOTHIAZINES IN THE TREATMENT OF NEWLY ADMITTED STATE HOSPITAL PATIENTS: GLOBAL COMPARISON OF EIGHT COMPOUNDS IN TERMS OF AN OUTCOME INDEX.

1 reference

12 December 2020

Metabolic Balance Studies on the Effect of Lithium Salts in Manic-Depressive Psychosis

1 reference

12 December 2020

[Structural analysis of psychopharmacological agents: experiments on the correlation of chemical structure and clinical action]

1 reference

12 December 2020

The Use of Lithium in Affective Disorders: I. Acute Endogenous Depression

1 reference

12 December 2020

Polypharmacy in Psychiatry: Patterns of Differential Treatment

1 reference

12 December 2020

Production of cortisol in patients with manic-depressive psychosis treated with Lithium Carbonate

1 reference

12 December 2020

Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions

1 reference

12 December 2020

The assay of chlorpromazine and metabolites in blood, urine, and other tissues

1 reference

12 December 2020

Studies of delayed-action medication V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine

1 reference

12 December 2020

Prophylactic lithium: another therapeutic myth? An examination of the evidence to date

1 reference

12 December 2020

Psychotic behavioral types. A cross-cultural comparison.

1 reference

12 December 2020

Predicting response to phenothiazines: the right drug for the right patient

1 reference

12 December 2020

EFFECTS OF A PHENOTHIAZINE AND/OR GROUP PSYCHOTHERAPY WITH SCHIZOPHRENICS

1 reference

12 December 2020

1 reference

12 December 2020

Chlorpromazine Retention

1 reference

12 December 2020

Lithium carbonate and kidney function. A failure in renal concentrating ability

1 reference

12 December 2020

Lithium Prophylaxis in Recurrent Affective Disorders

1 reference

12 December 2020

Effect of Lithium on the Uptake of Noradrenaline by Synaptosomes

1 reference

12 December 2020

Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients

1 reference

12 December 2020

The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites

1 reference

12 December 2020

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

1 reference

12 December 2020

Major psychiatric disorders. A four-dimensional model.

1 reference

12 December 2020

Very High Dosage Fluphenazine for Nonchronic Treatment-Refractory Patients

1 reference

12 December 2020

Long-term treatment of chronic schizophrenia. A preliminary report

1 reference

12 December 2020

Lithium in Pregnancy: A Review with Recommendations

1 reference

12 December 2020

The genetics of schizophrenic and schizoid disease

1 reference

12 December 2020

Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States

1 reference

12 December 2020

Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study

1 reference

12 December 2020

Chlorpromazine Plasma Levels and Effects

1 reference

12 December 2020

Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo

1 reference

12 December 2020

Clinical use of psychotherapeutic drugs: current status

1 reference

12 December 2020

L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients

1 reference

12 December 2020

Thiopropazate Hydrochloride in Persistent Dyskinesia

1 reference

12 December 2020

Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect

1 reference

12 December 2020

Biogenic Amines and Emotion

1 reference

12 December 2020

Lithium excretion and therapeutic response

1 reference

12 December 2020

Toward a biology of affective disorders. Genetic contributions

1 reference

12 December 2020

Prediction of response to phenothiazines in schizophrenia. A crossvalidation study

1 reference

12 December 2020

Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group

1 reference

12 December 2020

Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic Schizophrenics

1 reference

12 December 2020

10.2165/00003495-197204050-00001

Identifiers

DOI

0 references

PubMed ID

4568065

1 reference

PubMed ID

4568065